Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  AUSTRALIAN SECURITIES EXCHANGE LIMITED  >  Cochlear Limited    COH   AU000000COH5

COCHLEAR LIMITED (COH)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Securities Exc…
05/15/2018 05/16/2018 05/17/2018 05/18/2018 05/21/2018 Date
192.73(c) 197.46(c) 195.32(c) 196.78(c) 198.93 Last
193 469 164 350 123 843 78 995 66 430 Volume
-1.85% +2.45% -1.08% +0.75% +1.09% Change
More quotes
Financials (AUD)
Sales 2018 1 375 M
EBIT 2018 348 M
Net income 2018 246 M
Debt 2018 91,0 M
Yield 2018 1,55%
Sales 2019 1 524 M
EBIT 2019 394 M
Net income 2019 286 M
Debt 2019 74,2 M
Yield 2019 1,77%
P/E ratio 2018 45,86
P/E ratio 2019 39,47
EV / Sales2018 8,30x
EV / Sales2019 7,48x
Capitalization 11 321 M
More Financials
Company
Cochlear Ltd. engages in the provision of implantable hearing solutions.It operates through following segments: Americas; Europe, Middle East & Africa; and Asia Pacific.Its products include cochlear, bone conduction and acoustic implants.Cochlear was founded by Michael S. Hirshorn in 1981 and is... 
More about the company
Surperformance© ratings of Cochlear Limited
Trading Rating : Investor Rating :
More Ratings
Latest news on COCHLEAR LIMITED
05/17COCHLEAR : Patent Issued for Frequency Based Feedback Control (USPTO 9967680)
AQ
05/17COCHLEAR : Patent Issued for Optical Microphone for Implantable Hearing Instrume..
AQ
05/03COCHLEAR : Patent Issued for Suspended Components in Auditory Prostheses (USPTO ..
AQ
05/03COCHLEAR : Patent Issued for Bone Conduction Device Fitting (USPTO 9955270)
AQ
05/03COCHLEAR : ee Sound Differently,' take the #MillionEar Challenge to protect your..
AQ
04/30COCHLEAR : Launches ‘See Sound Differently’ Video Campaign for Bette..
AQ
04/19COCHLEAR : Patent Issued for Devices for Enhancing Transmissions of Stimuli in A..
AQ
04/13COCHLEAR : Federal Contracts Awarded by Federal Agencies in Texas (April 13)
AQ
04/13COCHLEAR : MILITARY $21,397 Federal Contract Awarded to Cochlear Americas
AQ
03/22COCHLEAR : Patent Issued for Alternate Stimulation Strategies for Perception of ..
AQ
More news
Sector news : Medical Prosthetics
05/16Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 billion
RE
05/16Sivantos and Widex in $8 billion merger to create No.3 in hearing aids
RE
05/10Shares of Medical Technology Companies Down After Hours on New Study--Market ..
DJ
05/10HEART DEVICE PROCEDURE IS NO BETTER : Study
DJ
05/08WILLIAM DEMANT A/S : shares plummet after growth outlook fails to impress
RE
More sector news : Medical Prosthetics
Latest Tweets
05/15Last month saw Australian hearing aid company Cochlear launch Hearprint, a br.. 
05/09Grandfather Back In The Conversation With Cochlear Implant
1
05/08Synchronizing Cochlear Signals Stimulates Brain to 'Hear' in Stereo Currentl..
12
05/08Synchronizing cochlear signals stimulates #brain to 'hear' in stereo @acousti..
1
05/07The sound of life-changing success: deaf infant youngest-ever Manitoban to ge..
4
More tweets
Qtime:59
News from SeekingAlpha
01/29Dividend Investing Has Made Me A Better Growth Investor 
2017Apple and Cochlear announce Sound Processor for hearing implant 
2017WEEK IN REVIEW : BGI Genomics Completes $81-Million Chi-Next IPO 
2016How Do I Manage A Favorite Holding That's Now Overvalued? 
2016Smaller Medtechs In Charge Of Their Own Destiny 
Chart COCHLEAR LIMITED
Duration : Period :
Cochlear Limited Technical Analysis Chart | COH | AU000000COH5 | 4-Traders
Technical analysis trends COCHLEAR LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 11
Average target price 162  AUD
Spread / Average Target -17%
EPS Revisions
Managers
NameTitle
Diggory William Howitt President, CEO & Executive Director
Roderick Holliday-Smith Chairman
Brent Cubis Chief Financial Officer
James F. Patrick Chief Scientist & Senior Vice President
Jan Janssen Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
COCHLEAR LIMITED14.92%8 504
STRAUMANN HOLDING-1.60%10 788
SONOVA HOLDING6.41%10 617
INSULET CORPORATION26.84%5 143
DENTIUM CO LTD--.--%908
MODERN DENTAL GROUP LTD4.13%289